<p>Supplementary Table S1;List of resources (antibodies, primers, siRNA).</p><p>Supplementary Table S2;DEG analysis of scRNA-seq data.</p><p>Supplementary Table S3;Upregulated GO terms of BP.</p><p>Supplementary Table S4;Downregulated GO terms of BP.</p><p>Supplementary Table S5;Motif enrichment calculated by FindMotifs tool.</p>
Funding
MEXT | Japan Society for the Promotion of Science (JSPS)
Osaka Medical Research Foundation for Intractable Diseases
This study reveals the epigenetic and transcriptional suppression mechanism of the fusion oncogene EWSR1::ATF1 in clear cell sarcoma by histone deacetylase inhibitor treatment as well as identifying SOX10 as a transcription factor that regulates EWSR1::ATF1 expression.